Skip to main content

Advertisement

SpringerLink
Log in

Differential ligand binding/trafficking for distinct CTLA-4 fates: is it an expandable mechanism?

  • Research Highlight
  • Published:
Cellular & Molecular Immunology Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Kennedy A, Waters E, Rowshanravan B, et al. Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation. Nat Immunol. 2022;23:1365–78.

    Article  CAS  Google Scholar 

  2. Hiam-Galvez KJ, Allen BM, Spitzer MH. Systemic immunity in cancer. Nat Rev Cancer. 2021;21:345–59.

    Article  CAS  Google Scholar 

  3. Elkoshi Z. Cancer and autoimmune diseases: a tale of two immunological opposites? Front Immunol. 2022;13:821598.

    Article  CAS  Google Scholar 

  4. Kim GR, Choi JM. Current understanding of cytotoxic T lymphocyte antigen-4 (CTLA-4) Signaling in T-cell biology and disease therapy. Mol Cells. 2022;45:513–21.

    Article  CAS  Google Scholar 

  5. Rowshanravan B, Halliday N, Sansom DM. CTLA-4: a moving target in immunotherapy. Blood. 2018;131:58–67.

    Article  CAS  Google Scholar 

  6. Lo B, Fritz JM, Su HC, Uzel G, Jordan MB, Lenardo MJ. CHAI and LATAIE: new genetic diseases of CTLA-4 checkpoint insufficiency. Blood. 2016;128:1037–42.

    Article  CAS  Google Scholar 

  7. Wing K, Onishi Y, Prieto-Martin P, et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science. 2008;322:271–5.

    Article  CAS  Google Scholar 

  8. Korman AJ, Garrett-Thomson SC, Lonberg N. The foundations of immune checkpoint blockade and the ipilimumab approval decennial. Nat Rev Drug Discov. 2022;21:509–28.

    Article  CAS  Google Scholar 

  9. Sugiura D, Maruhashi T, Okazaki IM, et al. Restriction of PD-1 function by cis-PD-L1/CD80 interactions is required for optimal T cell responses. Science. 2019;364:558–66.

    Article  CAS  Google Scholar 

  10. Zuidema A, Wang W, Sonnenberg A. Crosstalk between cell adhesion complexes in regulation of mechanotransduction. Bioessays. 2020;42:e2000119.

    Article  Google Scholar 

Download references

Author information

Author notes

  1. These authors contributed equally: Ji Eon Kim, Eunmi Kim.

Authors and Affiliations

  1. Department of Pharmacy, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea

    Ji Eon Kim, Eunmi Kim & Jung Weon Lee

Authors
  1. Ji Eon Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eunmi Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jung Weon Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jung Weon Lee.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, J.E., Kim, E. & Lee, J.W. Differential ligand binding/trafficking for distinct CTLA-4 fates: is it an expandable mechanism?. Cell Mol Immunol 20, 1–2 (2023). https://doi.org/10.1038/s41423-022-00945-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41423-022-00945-3

  • Springer Nature Limited

Search

Navigation